NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead 
China vs. NASA: The New Moon Race and What's at Stake by 2030 
Gulf Ministers to Meet Iran in Oman Over Hormuz Shipping Deal 
Apple Unveils $1,999 Foldable iPhone Duo 
Asian Currencies Steady as Yen Holds Firm, Oil Tops $100 
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
Longsys Raises $903 Million in Hong Kong IPO as Shares Debut Flat 
TSMC August Revenue Jumps 53% on AI Chip Demand 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Gold Prices Steady Ahead of U.S. Inflation Data and Fed Decision 
Kioxia Rules Out SK Hynix Manufacturing Partnership 
ECB Rate Hike in Focus as Oil Tops $100 
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions 
Blackstone Eyes $2 Billion ZO Skin Health Sale 
Add as a preferred source on Google
Kubota Pharmaceutical will sell specially designed glasses dubbed Kubota Glass, which it claims are able to reverse the effects of myopia.
The glasses shine tiny lights at the retina to simulate short-distance blurring, forcing the user to look further ahead and in doing so taking the pressure of the axial deformation of eyeballs.
Long-term testing is still required to gauge how effective Kubota Glass is at this in detail, but studies so far suggest that they are at least effective at curbing the progression of myopia.
Kubota Glass has been approved as a medical device in Taiwan and the USA.
Kubota Pharmaceutical charges 770,000 yen for a pair of Kubota Glass while offering a 100-percent satisfaction guarantee.
According to 2009 research conducted by Japan's Ministry of Education, Culture, Sports, Science, and Technology, around 25% of first-graders had less than perfect eyesight, with the percentage rising to 50% among sixth-graders.
